Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, July 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Thermo Fisher Scientific Expands Chromatography Portfolio Integrated to Waters Empower CDS
Monday, April 07, 2014
Analytical laboratories standardized on the Waters® Empower® Chromatography Data System (CDS) now have a wider choice of Thermo Scientific chromatography systems and modules which can be integrated into this environment.

QIAGEN Expands Product Portfolio for NGS and Cancer Research
Saturday, April 05, 2014
New innovative product launches at AACR Annual Meeting add to broad portfolio of NGS solutions.

Agilent Introduces Next-Generation UV-Vis Diode Array Spectrophotometer
Friday, April 04, 2014
Cary 8454 UV-Vis and optimized software ideal for pharmaceutical and highly regulated industries.

Waters Progenesis QI Marks Next Generation of LC-MS 'Omics Analysis
Friday, April 04, 2014
Company unveiled two new data analysis software packages for proteomics and metabolomics/lipidomics analyses: Progenesis® QI and Progenesis QI for Proteomics at Analytica.

Illumina Expands Product Portfolio
Thursday, April 03, 2014
End-to-end genomics solutions will transform the future of oncology.

Cancer Genetics Expands BioDiscovery's Nexus Copy Number Platform
Thursday, April 03, 2014
Expansion to identify novel biomarkers predictive of cancer outcomes.

Autoscribe Updates Matrix Gemini LIMS
Wednesday, April 02, 2014
Enhancement includes new functionality for the ‘runsheet’ function

Accelrys Notebook 5.0 Sets New Standards for Moving from Paper-Based to Digital Laboratories
Wednesday, April 02, 2014
Easy Configuration, Fast Adoption and Improved Productivity Drives Faster Innovation in Today's Science-Driven World

LabWare Releases New Version of LabWare LIMS Solution
Wednesday, April 02, 2014
Significant features include functional as well as performance enhancements.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 841
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv